IBDEI0OZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11669,1,4,0)
 ;;=4^G54.9
 ;;^UTILITY(U,$J,358.3,11669,2)
 ;;=^5004015
 ;;^UTILITY(U,$J,358.3,11670,0)
 ;;=G54.6^^47^534^103
 ;;^UTILITY(U,$J,358.3,11670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11670,1,3,0)
 ;;=3^Neuropathy,Phantom Limb Syndrome w/ Pain
 ;;^UTILITY(U,$J,358.3,11670,1,4,0)
 ;;=4^G54.6
 ;;^UTILITY(U,$J,358.3,11670,2)
 ;;=^5004013
 ;;^UTILITY(U,$J,358.3,11671,0)
 ;;=G54.7^^47^534^104
 ;;^UTILITY(U,$J,358.3,11671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11671,1,3,0)
 ;;=3^Neuropathy,Phantom Limb Syndrome w/o Pain
 ;;^UTILITY(U,$J,358.3,11671,1,4,0)
 ;;=4^G54.7
 ;;^UTILITY(U,$J,358.3,11671,2)
 ;;=^5004014
 ;;^UTILITY(U,$J,358.3,11672,0)
 ;;=G62.2^^47^534^105
 ;;^UTILITY(U,$J,358.3,11672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11672,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy d/t Toxic Agents
 ;;^UTILITY(U,$J,358.3,11672,1,4,0)
 ;;=4^G62.2
 ;;^UTILITY(U,$J,358.3,11672,2)
 ;;=^268531
 ;;^UTILITY(U,$J,358.3,11673,0)
 ;;=G62.82^^47^534^94
 ;;^UTILITY(U,$J,358.3,11673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11673,1,3,0)
 ;;=3^Neuropathy,Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,11673,1,4,0)
 ;;=4^G62.82
 ;;^UTILITY(U,$J,358.3,11673,2)
 ;;=^5004077
 ;;^UTILITY(U,$J,358.3,11674,0)
 ;;=G62.9^^47^534^106
 ;;^UTILITY(U,$J,358.3,11674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11674,1,3,0)
 ;;=3^Neuropathy,Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,11674,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,11674,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,11675,0)
 ;;=G57.90^^47^534^99
 ;;^UTILITY(U,$J,358.3,11675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11675,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,11675,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,11675,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,11676,0)
 ;;=G56.90^^47^534^101
 ;;^UTILITY(U,$J,358.3,11676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11676,1,3,0)
 ;;=3^Neuropathy,Mononeuropathy,Upper Limb,Unspec
 ;;^UTILITY(U,$J,358.3,11676,1,4,0)
 ;;=4^G56.90
 ;;^UTILITY(U,$J,358.3,11676,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,11677,0)
 ;;=R29.5^^47^534^107
 ;;^UTILITY(U,$J,358.3,11677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11677,1,3,0)
 ;;=3^Paralysis,Transient
 ;;^UTILITY(U,$J,358.3,11677,1,4,0)
 ;;=4^R29.5
 ;;^UTILITY(U,$J,358.3,11677,2)
 ;;=^5019316
 ;;^UTILITY(U,$J,358.3,11678,0)
 ;;=G83.9^^47^534^108
 ;;^UTILITY(U,$J,358.3,11678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11678,1,3,0)
 ;;=3^Paralytic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,11678,1,4,0)
 ;;=4^G83.9
 ;;^UTILITY(U,$J,358.3,11678,2)
 ;;=^5004151
 ;;^UTILITY(U,$J,358.3,11679,0)
 ;;=G82.20^^47^534^109
 ;;^UTILITY(U,$J,358.3,11679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11679,1,3,0)
 ;;=3^Paraplegia,Unspec
 ;;^UTILITY(U,$J,358.3,11679,1,4,0)
 ;;=4^G82.20
 ;;^UTILITY(U,$J,358.3,11679,2)
 ;;=^5004125
 ;;^UTILITY(U,$J,358.3,11680,0)
 ;;=G21.9^^47^534^111
 ;;^UTILITY(U,$J,358.3,11680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11680,1,3,0)
 ;;=3^Parkinsonism,Secondary,Unspec
 ;;^UTILITY(U,$J,358.3,11680,1,4,0)
 ;;=4^G21.9
 ;;^UTILITY(U,$J,358.3,11680,2)
 ;;=^5003778
 ;;^UTILITY(U,$J,358.3,11681,0)
 ;;=G20.^^47^534^110
 ;;^UTILITY(U,$J,358.3,11681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11681,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,11681,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,11681,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,11682,0)
 ;;=G14.^^47^534^114
 ;;^UTILITY(U,$J,358.3,11682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11682,1,3,0)
 ;;=3^Postpolio Syndrome
 ;;^UTILITY(U,$J,358.3,11682,1,4,0)
 ;;=4^G14.
